Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Arnold, PD; Siegel-Bartelt, J; Cytrynbaum, C; Teshima, I; Schachar, R
   Velo-cardio-facial syndrome: Implications of microdeletion 22q11 for schizophrenia and mood disorders
   AMERICAN JOURNAL OF MEDICAL GENETICS
   
   P.D. Arnold et al., "Velo-cardio-facial syndrome: Implications of microdeletion 22q11 for schizophrenia and mood disorders", AM J MED G, 105(4), 2001, pp. 354-362
2. Iqbal, MM; Gundlapalli, SP; Ryan, WG; Ryals, T; Passman, TE
   Effects of antimanic mood-stabilizing drugs on fetuses, neonates, and nursing infants
   SOUTHERN MEDICAL JOURNAL
   
   M.M. Iqbal et al., "Effects of antimanic mood-stabilizing drugs on fetuses, neonates, and nursing infants", SOUTH MED J, 94(3), 2001, pp. 304-322
3. Soares, JC
   Valproate treatment and the risk of hyperandrogenism and polycystic ovaries
   BIPOLAR DISORDERS
   
   J.C. Soares, "Valproate treatment and the risk of hyperandrogenism and polycystic ovaries", BIPOL DIS, 2(1), 2000, pp. 37-41
4. Boivin, DB
   Influence of sleep-wake and circadian rhythm disturbances in psychiatric disorders
   JOURNAL OF PSYCHIATRY & NEUROSCIENCE
   
   D.B. Boivin, "Influence of sleep-wake and circadian rhythm disturbances in psychiatric disorders", J PSYCH NEU, 25(5), 2000, pp. 446-458
5. Odishaw, J; Chen, C
   Effects of steady-state bupropion on the pharmacokinetics of lamotrigine in healthy subjects
   PHARMACOTHERAPY
   
   J. Odishaw e C. Chen, "Effects of steady-state bupropion on the pharmacokinetics of lamotrigine in healthy subjects", PHARMACOTHE, 20(12), 2000, pp. 1448-1453
6. Frye, MA; Ketter, TA; Kimbrell, TA; Dunn, RT; Speer, AM; Osuch, EA; Luckenbaugh, DA; Cora-Locatelli, G; Leverich, GS; Post, RM
   A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders
   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
   
   M.A. Frye et al., "A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders", J CL PSYCH, 20(6), 2000, pp. 607-614
7. Davis, LL; Ryan, W; Adinoff, B; Petty, F
   Comprehensive review of the psychiatric uses of valproate
   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
   
   L.L. Davis et al., "Comprehensive review of the psychiatric uses of valproate", J CL PSYCH, 20(1), 2000, pp. 1S-17S
8. Bowden, CL; Lecrubier, Y; Bauer, M; Goodwin, G; Greil, W; Sachs, G; von Knorring, L
   Maintenance therapies for classic and other forms of bipolar disorder
   JOURNAL OF AFFECTIVE DISORDERS
   
   C.L. Bowden et al., "Maintenance therapies for classic and other forms of bipolar disorder", J AFFECT D, 59, 2000, pp. S57-S67
9. Horowitz, R; Kotler, M; Shufman, E; Aharoni, S; Kremer, I; Cohen, H; Ebstein, RP
   Confirmation of an excess of the high enzyme activity COMT val allele in heroin addicts in a family-based haplotype relative risk study
   AMERICAN JOURNAL OF MEDICAL GENETICS
   
   R. Horowitz et al., "Confirmation of an excess of the high enzyme activity COMT val allele in heroin addicts in a family-based haplotype relative risk study", AM J MED G, 96(5), 2000, pp. 599-603
10. Hallikainen, T; Lachman, H; Saito, T; Volavka, J; Kauhanen, J; Salonen, JT; Ryynanen, OP; Koulu, M; Karvonen, MK; Pohjalainen, T; Syvalahti, E; Hietala, J; Tiihonen, J
    Lack of association between the functional variant of the catechol-o-methyltransferase (COMT) gene and early-onset alcoholism associated with severe antisocial behavior
    AMERICAN JOURNAL OF MEDICAL GENETICS
    
    T. Hallikainen et al., "Lack of association between the functional variant of the catechol-o-methyltransferase (COMT) gene and early-onset alcoholism associated with severe antisocial behavior", AM J MED G, 96(3), 2000, pp. 348-352
11. Kauhanen, J; Hallikainen, T; Tuomainen, TP; Koulu, M; Karvonen, MK; Salonen, JT; Tiihonen, J
    Association between the functional polymorphism of catechol-O-methyltransferase gene and alcohol consumption among social drinkers
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
    
    J. Kauhanen et al., "Association between the functional polymorphism of catechol-O-methyltransferase gene and alcohol consumption among social drinkers", ALC CLIN EX, 24(2), 2000, pp. 135-139
12. Tiihonen, J; Hallikainen, T; Lachman, H; Saito, T; Volavka, J; Kauhanen, J; Salonen, JT; Ryynanen, OP; Koulu, M; Karvonen, MK; Pohjalainen, T; Syvalahti, E; Hietala, J
    Association between the functional variant of the catechol-O-methyltransferase (COMT) gene and type 1 alcoholism
    MOLECULAR PSYCHIATRY
    
    J. Tiihonen et al., "Association between the functional variant of the catechol-O-methyltransferase (COMT) gene and type 1 alcoholism", MOL PSYCHI, 4(3), 1999, pp. 286-289
13. Van Gerpen, MW; Johnson, JE; Winstead, DK
    Mania in the geriatric patient population - A review of the literature
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
    
    M.W. Van Gerpen et al., "Mania in the geriatric patient population - A review of the literature", AM J GER PS, 7(3), 1999, pp. 188-202
14. Vanstraelen, M; Tyrer, SP
    Rapid cycling bipolar affective disorder in people with intellectual disability: a systematic review
    JOURNAL OF INTELLECTUAL DISABILITY RESEARCH
    
    M. Vanstraelen e S.P. Tyrer, "Rapid cycling bipolar affective disorder in people with intellectual disability: a systematic review", J INTEL DIS, 43, 1999, pp. 349-359
15. Ryan, ND; Bhatara, VS; Perel, JM
    Mood stabilizers in children and adolescents
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
    
    N.D. Ryan et al., "Mood stabilizers in children and adolescents", J AM A CHIL, 38(5), 1999, pp. 529-536
16. Weissel, M
    Treatment of psychiatric diseases with thyroid hormones
    ACTA MEDICA AUSTRIACA
    
    M. Weissel, "Treatment of psychiatric diseases with thyroid hormones", ACT MED AUS, 26(4), 1999, pp. 129-131
17. Eisenberg, J; Mei-Tal, G; Steinberg, A; Tartakovsky, E; Zohar, A; Gritsenko, I; Nemanov, L; Ebstein, RP
    Haplotype relative risk study of catechol-O-methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD): Association of the high-enzyme activity val allele with ADHD impulsive-hyperactive phenotype
    AMERICAN JOURNAL OF MEDICAL GENETICS
    
    J. Eisenberg et al., "Haplotype relative risk study of catechol-O-methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD): Association of the high-enzyme activity val allele with ADHD impulsive-hyperactive phenotype", AM J MED G, 88(5), 1999, pp. 497-502
18. Wirz-Justice, A; Quinto, C; Cajochen, C; Werth, E; Hock, C
    A rapid-cycling bipolar patient treated with long nights, bedrest, and light
    BIOLOGICAL PSYCHIATRY
    
    A. Wirz-Justice et al., "A rapid-cycling bipolar patient treated with long nights, bedrest, and light", BIOL PSYCHI, 45(8), 1999, pp. 1075-1077
19. Suppes, T; Webb, A; Paul, B; Carmody, T; Kraemer, H; Rush, AJ
    Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania
    AMERICAN JOURNAL OF PSYCHIATRY
    
    T. Suppes et al., "Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania", AM J PSYCHI, 156(8), 1999, pp. 1164-1169
20. POTENZA MN; MCDOUGLE CJ
    POTENTIAL OF ATYPICAL ANTIPSYCHOTICS IN THE TREATMENT OF NONPSYCHOTICDISORDERS
    CNS DRUGS
    
    M.N. Potenza e C.J. Mcdougle, "POTENTIAL OF ATYPICAL ANTIPSYCHOTICS IN THE TREATMENT OF NONPSYCHOTICDISORDERS", CNS DRUGS, 9(3), 1998, pp. 213-232
21. Marcotte, D
    Use of topiramate, a new anti-epileptic as a mood stabilizer
    JOURNAL OF AFFECTIVE DISORDERS
    
    D. Marcotte, "Use of topiramate, a new anti-epileptic as a mood stabilizer", J AFFECT D, 50(2-3), 1998, pp. 245-251
22. WEHR TA; TURNER EH; SHIMADA JM; LOWE CH; BARKER C; LEIBENLUFT E
    TREATMENT OF A RAPIDLY CYCLING BIPOLAR PATIENT BY USING EXTENDED BED REST AND DARKNESS TO STABILIZE THE TIMING AND DURATION OF SLEEP
    Biological psychiatry
    
    T.A. Wehr et al., "TREATMENT OF A RAPIDLY CYCLING BIPOLAR PATIENT BY USING EXTENDED BED REST AND DARKNESS TO STABILIZE THE TIMING AND DURATION OF SLEEP", Biological psychiatry, 43(11), 1998, pp. 822-828
23. WALDEN J; HESSLINGER B; GRUNZE H; BERGER M
    TREATMENT OF PSYCHIATRIC DISEASES WITH TH E ANTIEPILEPTIC DRUG VALPROATE
    Nervenheilkunde
    
    J. Walden et al., "TREATMENT OF PSYCHIATRIC DISEASES WITH TH E ANTIEPILEPTIC DRUG VALPROATE", Nervenheilkunde, 16(1), 1997, pp. 12-18
24. KECK PE; MCELROY SL; STRAKOWSKI SM
    NEW DEVELOPMENTS IN THE PHARMACOLOGICAL TREATMENT OF SCHIZOAFFECTIVE DISORDER
    The Journal of clinical psychiatry
    
    P.E. Keck et al., "NEW DEVELOPMENTS IN THE PHARMACOLOGICAL TREATMENT OF SCHIZOAFFECTIVE DISORDER", The Journal of clinical psychiatry, 57, 1996, pp. 41-48
25. BOWDEN CL
    DOSING STRATEGIES AND TIME-COURSE OF RESPONSE TO ANTIMANIC DRUGS
    The Journal of clinical psychiatry
    
    C.L. Bowden, "DOSING STRATEGIES AND TIME-COURSE OF RESPONSE TO ANTIMANIC DRUGS", The Journal of clinical psychiatry, 57, 1996, pp. 4-12
26. WALDEN J; HESSLINGER B
    SIGNIFICANCE OF OLD AND NEW ANTIEPILEPTIC DRUGS IN THE TREATMENT OF PSYCHIATRIC DISEASES
    Fortschritte der Neurologie, Psychiatrie
    
    J. Walden e B. Hesslinger, "SIGNIFICANCE OF OLD AND NEW ANTIEPILEPTIC DRUGS IN THE TREATMENT OF PSYCHIATRIC DISEASES", Fortschritte der Neurologie, Psychiatrie, 63(8), 1995, pp. 320-335
27. BOWDEN CL
    PREDICTORS OF RESPONSE TO DIVALPROEX AND LITHIUM
    The Journal of clinical psychiatry
    
    C.L. Bowden, "PREDICTORS OF RESPONSE TO DIVALPROEX AND LITHIUM", The Journal of clinical psychiatry, 56, 1995, pp. 25-30
28. EMILIEN G; MALOTEAUX JM; SEGHERS A; CHARLES G
    LITHIUM-THERAPY IN THE TREATMENT OF MANIC-DEPRESSIVE ILLNESS - PRESENT STATUS AND FUTURE PERSPECTIVES - A CRITICAL-REVIEW
    Archives internationales de pharmacodynamie et de therapie
    
    G. Emilien et al., "LITHIUM-THERAPY IN THE TREATMENT OF MANIC-DEPRESSIVE ILLNESS - PRESENT STATUS AND FUTURE PERSPECTIVES - A CRITICAL-REVIEW", Archives internationales de pharmacodynamie et de therapie, 330(3), 1995, pp. 251-278
29. BALFOUR JA; BRYSON HM
    VALPROIC ACID - A REVIEW OF ITS PHARMACOLOGY AND THERAPEUTIC POTENTIAL IN INDICATIONS OTHER THAN EPILEPSY
    CNS DRUGS
    
    J.A. Balfour e H.M. Bryson, "VALPROIC ACID - A REVIEW OF ITS PHARMACOLOGY AND THERAPEUTIC POTENTIAL IN INDICATIONS OTHER THAN EPILEPSY", CNS DRUGS, 2(2), 1994, pp. 144-173
30. ANANTH J; WOHL M; RANGANATH V; BESHAY M
    RAPID-CYCLING PATIENTS - CONCEPTUAL AND ETIOLOGIC FACTORS
    Neuropsychobiology
    
    J. Ananth et al., "RAPID-CYCLING PATIENTS - CONCEPTUAL AND ETIOLOGIC FACTORS", Neuropsychobiology, 27(4), 1993, pp. 193-198
31. NABER D; BOMMER M
    SUBCLINICAL HYPOTHYROIDISM IN RECURRENT MANIA - RESPONSE
    Biological psychiatry
    
    D. Naber e M. Bommer, "SUBCLINICAL HYPOTHYROIDISM IN RECURRENT MANIA - RESPONSE", Biological psychiatry, 33(11-12), 1993, pp. 854-854